Clozapine's secret? small study probes inflammation link in tough schizophrenia cases
NCT ID NCT05741502
First seen Feb 27, 2026 · Last updated May 17, 2026 · Updated 11 times
Summary
This study aimed to see if clozapine, a medication for treatment-resistant schizophrenia, reduces inflammation more than other antipsychotics. Researchers planned to measure inflammatory markers in the blood of 5 participants. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ohio State University Harding Hospital
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.